Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

ACR Appropriateness Criteria® Tinnitus.

Expert Panel on Neurologic Imaging:, Kessler MM, Moussa M, Bykowski J, Kirsch CFE, Aulino JM, Berger KL, Choudhri AF, Fife TD, Germano IM, Kendi AT, Kim JH, Luttrull MD, Nunez D Jr, Shah LM, Sharma A, Shetty VS, Symko SC, Cornelius RS.

J Am Coll Radiol. 2017 Nov;14(11S):S584-S591. doi: 10.1016/j.jacr.2017.08.052.

PMID:
29101995
2.

ACR Appropriateness Criteria® Sinonasal Disease.

Expert Panel on Neurologic Imaging:, Kirsch CFE, Bykowski J, Aulino JM, Berger KL, Choudhri AF, Conley DB, Luttrull MD, Nunez D Jr, Shah LM, Sharma A, Shetty VS, Subramaniam RM, Symko SC, Cornelius RS.

J Am Coll Radiol. 2017 Nov;14(11S):S550-S559. doi: 10.1016/j.jacr.2017.08.041.

PMID:
29101992
3.

ACR Appropriateness Criteria® Plexopathy.

Expert Panel on Neurologic Imaging:, Bykowski J, Aulino JM, Berger KL, Cassidy RC, Choudhri AF, Kendi AT, Kirsch CFE, Luttrull MD, Sharma A, Shetty VS, Than K, Winfree CJ, Cornelius RS.

J Am Coll Radiol. 2017 May;14(5S):S225-S233. doi: 10.1016/j.jacr.2017.02.002. Review.

PMID:
28473078
4.

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.

Berger KL, Sarrazin C, Nelson DR, Scherer J, Sha N, Marquis M, Côté-Martin A, Vinisko R, Stern JO, Mensa FJ, Kukolj G.

PLoS One. 2016 Aug 5;11(8):e0160668. doi: 10.1371/journal.pone.0160668. eCollection 2016.

5.

ACR Appropriateness Criteria Head Trauma.

Shetty VS, Reis MN, Aulino JM, Berger KL, Broder J, Choudhri AF, Kendi AT, Kessler MM, Kirsch CF, Luttrull MD, Mechtler LL, Prall JA, Raksin PB, Roth CJ, Sharma A, West OC, Wintermark M, Cornelius RS, Bykowski J.

J Am Coll Radiol. 2016 Jun;13(6):668-79. doi: 10.1016/j.jacr.2016.02.023.

PMID:
27262056
6.

Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection.

Nishiguchi S, Urano Y, Suzaki K, Taniguchi A, Scherer J, Berger KL, Quinson AM, Stern JO, Omata M.

Hepatol Res. 2017 Mar;47(3):E142-E151. doi: 10.1111/hepr.12741. Epub 2016 Aug 10.

PMID:
27153246
7.

ACR Appropriateness Criteria Myelopathy.

Roth CJ, Angevine PD, Aulino JM, Berger KL, Choudhri AF, Fries IB, Holly LT, Kendi AT, Kessler MM, Kirsch CF, Luttrull MD, Mechtler LL, O'Toole JE, Sharma A, Shetty VS, West OC, Cornelius RS, Bykowski J.

J Am Coll Radiol. 2016 Jan;13(1):38-44. doi: 10.1016/j.jacr.2015.10.004. Epub 2015 Nov 30.

PMID:
26653797
8.

Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies.

Berger KL, Scherer J, Ranga M, Sha N, Stern JO, Quinson AM, Kukolj G.

Antimicrob Agents Chemother. 2015 Oct;59(10):6017-25. doi: 10.1128/AAC.00932-15. Epub 2015 Jul 20.

9.

Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.

Chukkapalli V, Berger KL, Kelly SM, Thomas M, Deiters A, Randall G.

Virology. 2015 Feb;476:168-179. doi: 10.1016/j.virol.2014.12.018. Epub 2014 Dec 26.

10.

Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir.

Berger KL, Triki I, Cartier M, Marquis M, Massariol MJ, Böcher WO, Datsenko Y, Steinmann G, Scherer J, Stern JO, Kukolj G.

Antimicrob Agents Chemother. 2014;58(2):698-705. doi: 10.1128/AAC.01976-13. Epub 2013 Nov 11.

11.

Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study.

Berger KL, Lagacé L, Triki I, Cartier M, Marquis M, Lawetz C, Bethell R, Scherer J, Kukolj G.

Antimicrob Agents Chemother. 2013 Oct;57(10):4928-36. doi: 10.1128/AAC.00822-13. Epub 2013 Jul 22.

12.

Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.

Larrey D, Lohse AW, Trepo C, Bronowicki JP, Arastéh K, Bourlière M, Calleja JL, Stern JO, Nehmiz G, Abdallah N, Berger KL, Marquis M, Steffgen J, Kukolj G; BI 207127 Study Group.

Antimicrob Agents Chemother. 2013 Oct;57(10):4727-35. doi: 10.1128/AAC.00565-13. Epub 2013 Jul 15.

13.

Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.

Ballegeer EA, Madrill NJ, Berger KL, Agnew DW, McNiel EA.

BMC Cancer. 2013 Apr 30;13:218. doi: 10.1186/1471-2407-13-218.

14.

ACR appropriateness criteria sinonasal disease.

Cornelius RS, Martin J, Wippold FJ 2nd, Aiken AH, Angtuaco EJ, Berger KL, Brown DC, Davis PC, McConnell CT Jr, Mechtler LL, Nussenbaum B, Roth CJ, Seidenwurm DJ; American College of Radiology.

J Am Coll Radiol. 2013 Apr;10(4):241-6. doi: 10.1016/j.jacr.2013.01.001. Epub 2013 Feb 16.

PMID:
23420025
15.

Alzheimer's disease and amnestic mild cognitive impairment weaken connections within the default-mode network: a multi-modal imaging study.

Zhu DC, Majumdar S, Korolev IO, Berger KL, Bozoki AC.

J Alzheimers Dis. 2013;34(4):969-84. doi: 10.3233/JAD-121879.

PMID:
23313926
16.

Molecular determinants and dynamics of hepatitis C virus secretion.

Coller KE, Heaton NS, Berger KL, Cooper JD, Saunders JL, Randall G.

PLoS Pathog. 2012 Jan;8(1):e1002466. doi: 10.1371/journal.ppat.1002466. Epub 2012 Jan 5.

17.

Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication.

Berger KL, Kelly SM, Jordan TX, Tartell MA, Randall G.

J Virol. 2011 Sep;85(17):8870-83. doi: 10.1128/JVI.00059-11. Epub 2011 Jun 22.

18.

Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: a DTI/FDG-PET study.

Bozoki AC, Korolev IO, Davis NC, Hoisington LA, Berger KL.

Hum Brain Mapp. 2012 Aug;33(8):1792-802. doi: 10.1002/hbm.21320. Epub 2011 Jun 14.

PMID:
21674695
19.

Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis.

Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, Kuhn RJ, Randall G.

Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17345-50. doi: 10.1073/pnas.1010811107. Epub 2010 Sep 20.

20.

Possibilities for RNA interference in developing hepatitis C virus therapeutics.

Berger KL, Randall G.

Viruses. 2010 Aug;2(8):1647-65. doi: 10.3390/v2081647. Epub 2010 Aug 6.

21.
22.

RNA interference and single particle tracking analysis of hepatitis C virus endocytosis.

Coller KE, Berger KL, Heaton NS, Cooper JD, Yoon R, Randall G.

PLoS Pathog. 2009 Dec;5(12):e1000702. doi: 10.1371/journal.ppat.1000702. Epub 2009 Dec 24.

23.

Automated PET/CT brain registration for accurate attenuation correction.

Khurshid K, Berger KL, McGough RJ.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:5805-8. doi: 10.1109/IEMBS.2009.5335188.

PMID:
19965247
24.

Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.

Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, Mateu G, Grakoui A, Randall G.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7577-82. doi: 10.1073/pnas.0902693106. Epub 2009 Apr 17.

25.

Breast MR imaging: applications and pitfalls.

Hoisington LA, Scherer DL, Berger KL.

Radiol Technol. 2007 May-Jun;78(5):367-77. Review.

PMID:
17519373
26.

Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Berger KL, Barriga F, Lace MJ, Turek LP, Zamba GJ, Domann FE, Lee JH, Klingelhutz AJ.

Virology. 2006 Dec 5-20;356(1-2):68-78. Epub 2006 Aug 30.

27.

Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism.

Lee JH, Yi SM, Anderson ME, Berger KL, Welsh MJ, Klingelhutz AJ, Ozbun MA.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2094-9. Epub 2004 Feb 9.

28.

Asymmetry of subinsular anisotropy by in vivo diffusion tensor imaging.

Cao Y, Whalen S, Huang J, Berger KL, DeLano MC.

Hum Brain Mapp. 2003 Oct;20(2):82-90.

29.

Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes.

Sprague DL, Phillips SL, Mitchell CJ, Berger KL, Lace M, Turek LP, Klingelhutz AJ.

Virology. 2002 Sep 30;301(2):247-54.

30.

FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

Berger KL, Nicholson SA, Dehdashti F, Siegel BA.

AJR Am J Roentgenol. 2000 Apr;174(4):1005-8.

PMID:
10749239
31.

Evaluation of femoral prosthetic loosening using CT imaging.

Reinus WR, Merkel KC, Gilden JJ, Berger KL.

AJR Am J Roentgenol. 1996 Jun;166(6):1439-42. No abstract available.

PMID:
8633459
32.

Stereotaxic summation analysis of human cerebral benzodiazepine binding maps.

Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE.

J Cereb Blood Flow Metab. 1996 May;16(3):409-17.

PMID:
8621745
33.

Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli.

Casey KL, Minoshima S, Berger KL, Koeppe RA, Morrow TJ, Frey KA.

J Neurophysiol. 1994 Feb;71(2):802-7.

PMID:
8176441
34.

Optimization of Butterworth filter for brain SPECT imaging.

Minoshima S, Maruno H, Yui N, Togawa T, Kinoshita F, Kubota M, Berger KL, Uchida Y, Uno K, Arimizu N.

Ann Nucl Med. 1993 May;7(2):71-7.

PMID:
8318350
35.

Automated detection of the intercommissural line for stereotactic localization of functional brain images.

Minoshima S, Koeppe RA, Mintun MA, Berger KL, Taylor SF, Frey KA, Kuhl DE.

J Nucl Med. 1993 Feb;34(2):322-9.

36.

An automated method for rotational correction and centering of three-dimensional functional brain images.

Minoshima S, Berger KL, Lee KS, Mintun MA.

J Nucl Med. 1992 Aug;33(8):1579-85.

37.

The prophylactic properties of the Today sponge and other spermicide containing contraceptives.

Berger KL, Remington K.

Adv Contracept. 1987 Jun;3(2):125-31. Review. No abstract available.

PMID:
2820207
38.

Comparison of oral feeding of peptide and amino acid meals to normal human subjects.

Silk DB, Chung YC, Berger KL, Conley K, Beigler M, Sleisenger MH, Spiller GA, Kim YS.

Gut. 1979 Apr;20(4):291-9.

39.

High speed optical stopped-flow apparatus.

Berger KL, Balko B, Borcherdt W, Friauff W.

Rev Sci Instrum. 1968 Apr;39(4):486-93. No abstract available.

PMID:
5641803

Supplemental Content

Loading ...
Support Center